FCMT
LSTA icon

Founders Capital Management (Texas)’s Lisata Therapeutics LSTA Stock Holding History

Founders Capital Management (Texas)’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.35K Hold
1,667
– – ﹤0.01% 325
2025
Q4 		$3.1K Sell
1,667
-333
-17% -$740 ﹤0.01% 355
2025
Q3 		$5.24K Hold
2,000
– – ﹤0.01% 327
2025
Q2 		$5.8K Hold
2,000
– – ﹤0.01% 309
2025
Q1 		$4.7K Hold
2,000
– – ﹤0.01% 310
2024
Q4 		$5.96K Hold
2,000
– – ﹤0.01% 300
2024
Q3 		$6K Hold
2,000
– – ﹤0.01% 309
2024
Q2 		$6.94K Buy
2,000
+1,667
+501% +$5.08K ﹤0.01% 302
2024
Q1 		$1.04K Hold
333
– – ﹤0.01% 336
2023
Q4 		$909 Sell
333
-333
-50% -$782 ﹤0.01% 363
2023
Q3 		$1.43K Hold
666
– – ﹤0.01% 376
2023
Q2 		$2.46K Hold
666
– – ﹤0.01% 356
2023
Q1 		$2K Hold
666
– – ﹤0.01% 364
2022
Q4 		$2K Hold
666
– – ﹤0.01% 358
2022
Q3 		$3K Sell
666
-1
-0.1% -$7 ﹤0.01% 357
2022
Q2 		$5K Buy
667
+334
+100% +$2.75K ﹤0.01% 367
2022
Q1 		$4K Hold
333
– – ﹤0.01% 292
2021
Q4 		$4K Sell
333
-667
-67% -$10.3K ﹤0.01% 292
2021
Q3 		$18K Hold
1,000
– – 0.01% 225
2021
Q2 		$24K Buy
+1,000
New +$23.7K 0.02% 186

Other funds holding LSTA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Founders Capital Management (Texas)'s LSTA Position: Q1 2026 in Review

Founders Capital Management (Texas) held its Lisata Therapeutics (LSTA) position steady in Q1 2026 at 1,667 shares worth $8.35K. The position accounts for ﹤0.01% of the portfolio, ranked #325.

Founders Capital Management (Texas) first reported a position in LSTA in Q2 2021 and has held it in 20 quarters since. The position peaked at $24K in Q2 2021. 34 funds tracked by Wall St. Rank hold LSTA as of Q1 2026.

  • Founders Capital Management (Texas) held 1,667 shares of Lisata Therapeutics worth $8.35K as of Q1 2026.
  • Founders Capital Management (Texas) left its Lisata Therapeutics share count unchanged in Q1 2026.
  • Lisata Therapeutics made up ﹤0.01% of Founders Capital Management (Texas)'s portfolio in Q1 2026, its #325 holding.
  • Founders Capital Management (Texas) first reported a position in Lisata Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Founders Capital Management (Texas)'s Lisata Therapeutics position peaked at $24K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2026.

Based on Founders Capital Management (Texas)'s 13F filing for Q1 2026, filed 21 Apr 2026.